𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ido serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

✍ Scribed by Aikou Okamoto; Takashi Nikaido; Kazunori Ochiai; Satoshi Takakura; Miho Takao; Misato Saito; Yuko Aoki; Nobuya Ishii; Nozomu Yanaihara; Kyosuke Yamada; Osamu Takikawa; Rie Kawaguchi; Seiji Isonishi; Tadao Tanaka; Mitsuyoshi Urashima


Book ID
119258055
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
580 KB
Volume
1304
Category
Article
ISSN
0531-5131

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


M-CAM expression as marker of poor progn
✍ Daniela Aldovini; Francesca Demichelis; Claudio Doglioni; Dolores Di Vizio; Enzo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 298 KB πŸ‘ 1 views

## Abstract Currently available clinico–pathologic criteria provide an imperfect assessment of outcome for patients with advanced epithelial ovarian cancer (EOC). Identification of prognostic factors related to tumor biology might improve this assessment. We investigated the prognostic significance

Reduced bikunin gene expression as a fac
✍ Yoshiko Tanaka; Hiroshi Kobayashi; Mika Suzuki; Naohiro Kanayama; Mitsuaki Suzuk πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Abstract ## BACKGROUND In previous studies, the authors showed that various types of cultured tumor cells treated with exogenous bikunin protein or ovarian carcinoma cells transfected with bikunin cDNA have low invasiveness and diminished metastatic potential. This study was carried out to clar

Gene expression profiles in primary ovar
✍ Alessandro D. Santin; Fenghuang Zhan; Stefania Bellone; Michela Palmieri; Stefan πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 550 KB

## Abstract With the goal of identifying genes with a differential pattern of expression between ovarian serous papillary carcinomas (OSPCs) and normal ovarian (NOVA) epithelium and using this knowledge for the development of novel diagnostic and therapeutic markers for ovarian cancer, we used olig